Dr Laurent Décory, BlueJet Consulting Managing Director, joins Aurealis Therapeutics as COO
Aurealis Therapeutics, a synthetic biology company developing ground-breaking four-in-one cell and gene therapies, announced today that...
Dr Laurent Décory, BlueJet Consulting Managing Director, joins Aurealis Therapeutics as COO
Biopharma grabs 55 new approvals in 2021
A very happy new year to our friends and partners
How can Pharma and MedTech succeed with Hybrid Launches ?
Engaging with patients: a must for MedTech
Curevac partners with Bayer Pharma to boost mRNA Covid vaccine
Happy New Year from BlueJet Consulting to our friends, partners, colleagues and clients
Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets
Covid has moved Pharma & MedTech to Omni-Channel for good: time to prepare a new GoToMarket strategy
COVID-19 to reshape R&D investments toward infectious diseases
mRNA-based vaccines: a story of immigration, science and resilience
Telehealth integrated into care mix by clinical teams
Covid-19 vaccine approval to massively accelerate mRNA innovation
Healthtech is coming of age, from AI drug discovery to omni-channel commercialization
Prepare post-Covid GoToMarket through adapted mix of remote and customer facing activities
Amazon launches its online pharmacy, to reshape multi-billion market
The end of Swedish Covid-19 exception ?
Moderna Covid-19 vaccine: 94% efficacy with easier storage
Accelerating healthcare innovation throughout the pandemic
How will Covid-19 vaccines impact economic recovery ?